Collectively, these findings suggest that suppressing the activation of the mTOR signaling axis could potentially reduce cellular senescence and mitigate osteoarthritis-associated chondrocyte catabolism, promoting an anabolic phenotype. The gene discussed is MTOR; the disease is osteoarthritis.